26006194
Results 1 to 1 of 1
Selection :
A randomized comparative 96-week trial of boosted atazanavir versus continued boosted protease inhibitor in HIV-1 patients with abdominal adiposityMOYLE, Graeme J; ANDRADE-VILLANUEVA, Jaime; BALOGH, Agnes et al.Antiviral therapy (London). 2012, Vol 17, Num 4, pp 689-700, issn 1359-6535, 12 p.Article
